Hospital News and Research

RSS

Positive results from second phase of ABSORB clinical trial on BVS technology

Abbott today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (ischemia-driven target lesion revascularization) and a very low rate of major adverse cardiac events (MACE(1) rate of 2.0 percent) at 30 days.

15 Mar 2010

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

The presence of plaque on an abdominal CT scan is a strong predictor of coronary artery disease and mortality, according to a Henry Ford Hospital study.

15 Mar 2010

Rhythm Pharmaceuticals completes $21M Series A equity financing

Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that it has completed the first close on its Series A equity financing of $21 million. The financing was led by MPM Capital and New Enterprise Associates. The funds will be used to develop products licensed from Ipsen.

15 Mar 2010

Study finds new way to reduce risk of life-threatening bloodstream infections in newborns

Hospitals may reduce the risk of life-threatening bloodstream infections in newborns with peripherally inserted central venous catheters by replacing the device every 30 days or so, according to a new Johns Hopkins Children's Center study.

15 Mar 2010

All claims brought against Medical Properties Trust and other entities rejected

Medical Properties Trust, Inc. announced today that a State District Court jury in Harris County, Texas rejected all claims brought against the company and other entities by a group of physicians whose efforts to create and operate a new hospital in Houston failed in 2006.

15 Mar 2010

VEGF-B protein can control levels of FATPs in vascular wall: Study

A new study from the Swedish medical university Karolinska Institutet shows that the blood vessels and muscles of the heart can regulate the uptake of fatty acids that we ingest through meat, milk products and other food. The researchers behind the study have also identified the way in which regulation is governed by the muscles themselves.

15 Mar 2010

DMC announces new agreements with Henry Ford West Bloomfield Hospital and Hurley Medical Center

Detroit Medical Center's Children's Hospital of Michigan has established new agreements with Henry Ford West Bloomfield Hospital and Hurley Medical Center in Flint to expand pediatric surgical expertise at these hospitals. As part of these agreements, pediatric surgeons from the Children's Hospital of Michigan are now performing outpatient surgical procedures and operations at these two health care facilities. In addition, the DMC has established a new Children's Hospital of Michigan Specialty Center at 5635 West Maple Road in West Bloomfield to house pediatric surgery services for patients.

15 Mar 2010

NCCN Guidelines and impact of escalating health care costs highlighted at NCCN Annual Conference

The escalating costs of cancer care combined with variations in concordance with evidence-based practice guidelines is putting the United States on a collision course for an impending collapse of its current health care system according to roundtable panelists at the NCCN 15th Annual Conference.

15 Mar 2010

Mitral regurgitation: MitraClip safe, effective alternative option to open heart surgery

NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented data today at the American College of Cardiology annual scientific sessions from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy) demonstrating the MitraClip, a novel, first-in-class catheter-based device, is a safe and effective alternative to open heart surgery for select patients with mitral regurgitation.

15 Mar 2010

Multimedia software program developed to help prostate cancer patients make treatment decisions

Mount Sinai School of Medicine is leading a study of patients newly-diagnosed with prostate cancer to determine if providing them with multimedia materials can help them make more informed treatment decisions. Michael Diefenbach, Ph.D., Associate Professor of Urology at Mount Sinai School of Medicine developed a multimedia software program designed to help prostate cancer patients and their families make treatment decisions.

15 Mar 2010

Older patients receive potentially inappropriate medications when treated in emergency room: Study

A University of Michigan study recently published in Academic Emergency Medicine says that it is common for patients 65 and older to receive potentially inappropriate medications when treated in an emergency room.

15 Mar 2010

New trial comparing drug-eluting stents to bypass graft surgery in left main coronary artery disease patients

The announcement of a new clinical trial, EXCEL (Evaluation of Xience Prime versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization), that will compare drug-eluting stents to coronary artery bypass graft surgery in patients with left main coronary artery disease, was made today at "Optimizing PCI Outcomes: Evolving Paradigms," a symposium presented by the Cardiovascular Research Foundation.

15 Mar 2010

Study: Chromosomal microarray analysis detects genetic changes related to ASDs better than standard tests

A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three times the detection rate for genetic changes related to autism spectrum disorders (ASDs) than standard tests. Publishing in the April issue of Pediatrics (and online March 15), the authors urge that CMA become part of the first-line genetic work-up for ASDs.

15 Mar 2010

Regadenoson drug is safe for heart transplant patients: Study

The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a Henry Ford Hospital study.

15 Mar 2010

Family history of CAD is a significant predictor of obstructive coronary artery disease

In the largest study of its kind to date using cardiac computed tomography angiography, people with a family history of early signs of coronary artery disease are at higher risk of developing obstructive coronary artery disease and plaque in their arteries, Henry Ford Hospital researchers say.

15 Mar 2010

Latest treatment options for colorectal cancer highlighted at NCCN Annual Conference

Despite statistics stating that colorectal cancer is the fourth most frequently diagnosed cancer in men and women in the United States, mortality from colon cancer has decreased slightly over the past 30 years, possibly because of earlier diagnoses through screening and better treatment modalities.

15 Mar 2010

Total knee replacement surgery more common among younger patients

A research team led by Mayo Clinic has found a national trend toward younger, more diverse patients having total knee replacement surgery.

15 Mar 2010

Supplementing vitamin D in people with low levels may have different effects based on patient race

Vitamin D is quickly becoming the "go-to" remedy for treating a wide range of illnesses, from osteoporosis to atherosclerosis. However, new evidence from a Wake Forest University School of Medicine study suggests that supplementing vitamin D in those with low levels may have different effects based on patient race and, in black individuals, the supplement could actually do harm.

15 Mar 2010

Challenges in treating AML and recent updates to NCCN Guidelines presented at NCCN Annual Conference

Using risk stratification to assist in treatment selection was just one of the focal points at a recent presentation of the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Acute Myeloid Leukemia (AML) at the NCCN 15th Annual Conference.

15 Mar 2010

Landmark clinical trial examines effective treatment options for childhood epilepsy

One of the oldest available anti-seizure medications, ethosuximide, is the most effective treatment for childhood absence epilepsy, according to initial outcomes published in this week's New England Journal of Medicine.

15 Mar 2010

Hospital News and Research

Positive results from second phase of ABSORB clinical trial on BVS technology

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

Rhythm Pharmaceuticals completes $21M Series A equity financing

Study finds new way to reduce risk of life-threatening bloodstream infections in newborns

All claims brought against Medical Properties Trust and other entities rejected

VEGF-B protein can control levels of FATPs in vascular wall: Study

DMC announces new agreements with Henry Ford West Bloomfield Hospital and Hurley Medical Center

NCCN Guidelines and impact of escalating health care costs highlighted at NCCN Annual Conference

Mitral regurgitation: MitraClip safe, effective alternative option to open heart surgery

Multimedia software program developed to help prostate cancer patients make treatment decisions

Older patients receive potentially inappropriate medications when treated in emergency room: Study

New trial comparing drug-eluting stents to bypass graft surgery in left main coronary artery disease patients

Study: Chromosomal microarray analysis detects genetic changes related to ASDs better than standard tests

Regadenoson drug is safe for heart transplant patients: Study

Family history of CAD is a significant predictor of obstructive coronary artery disease

Latest treatment options for colorectal cancer highlighted at NCCN Annual Conference

Total knee replacement surgery more common among younger patients

Supplementing vitamin D in people with low levels may have different effects based on patient race

Challenges in treating AML and recent updates to NCCN Guidelines presented at NCCN Annual Conference

Landmark clinical trial examines effective treatment options for childhood epilepsy

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News